A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)

  • Bellone, S.; 
  • Roque, D. M.; 
  • Siegel, E. R.; 
  • Buza, N.; 
  • Hui, P.; 
  • ... Choi, J.; 
  • 외 27명
Citations

WEB OF SCIENCE

37
Citations

SCOPUS

42

초록

[No Abstract Available.]

제목
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)
저자
Bellone, S.; Roque, D. M.; Siegel, E. R.; Buza, N.; Hui, P.; Bonazzoli, E.; Guglielmi, A.; Zammataro, L.; Nagarkatti, N.; Zaidi, S.; Lee, J.; Silasi, D-A; Huang, G. S.; Andikyan, V.; Damast, S.; Clark, M.; Azodi, M.; Schwartz, P. E.; Tymon-Rosario, J.; Harold, J.; Mauricio, D.; Zeybek, B.; Menderes, G.; Altwerger, G.; Ratner, E.; Alexandrov, L. B.; Iwasaki, A.; Kong, Y.; Song, E.; Dong, W.; Elvin, J.; Choi, J.; Santin, A. D.
DOI
10.1016/j.annonc.2021.04.013
발행일
2021-08
유형
Letter
저널명
Annals of Oncology
권
32
호
8
페이지
1045 ~ 1046